FIGURE 4.
A, Percent of patients with breakthrough CINV on Days 1‐5: high dose (≥70 mg/m2) cisplatin subset. B, Percent of patients with breakthrough significant nausea on Days 1‐5: high dose (≥70 mg/m2) cisplatin subset
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.